Company: HCWB
Filing Date: 2025-02-21
Form Type: DEF 14A
Source: 0001193125-25-032115
Chunk: 35

Company: HCW Biologics Inc.
Filing Date: 2025-02-21
Form: DEF 14A
Chunk 35
---
   0.90 | % |
| Rick S. Greene                    |     | Board Member              |     |           |    25,000 |     |                    |   0.40 | % |
| Lee Flowers                       |     | SVP, Business Development |     |           |    25,000 |     |                    |   0.40 | % |
| Officers and Directors as a Group |     |                           |     | $         | 2,875,000 |     |                    |  41.70 | % |
| Total Outstanding Principal       |     |                           |     | $         | 6,905,000 |     |                    | 100.00 | % |

All of the Noteholders who are also stockholders will abstain from voting on Proposal Three. Vote Required Assuming that a quorum is present at the Special Meeting, approval of Proposal Three requires the affirmative vote of the majority of the votes cast (meaning the number of shares voted “for ”the proposal must exceed the number of shares voted “against ”the proposal); provided, however, that the vote of any shares of our Common Stock issued to Noteholders will not be counted in determining whether or not this proposal is approved. Any shares that are not voted on the proposal for any reason, including abstentions and Broker Non-Votes,will not be counted as votes cast and accordingly will not affect the outcome of the proposal, but such votes will be counted for purposes of determining the presence or absence of a quorum. SINCE FOUR OF FIVE DIRECTORS ARE ALSO NOTEHOLDERS, OUR BOARD ABSTAINS FROM MAKING A RECOMMENDATION WITH RESPECT TO PROPOSAL THREE. 22

HOUSEHOLDING

Some banks, brokers and other nominee record holders may be participating in the practice of “householding” proxy statements and
annual reports. This means that only one copy of our documents, including this proxy statement, may have been sent to multiple stockholders in your household if you have requested paper copies thereof. We will promptly deliver a separate copy of
either document to you upon written or oral request to HCW Biologics Inc., 2929 N. Commerce Parkway, Miramar, Florida 33025, Attention: Corporate Secretary or (954) 842-2024 X205. If you want to receive
separate copies of the proxy statement in the future, or if you are receiving multiple copies and would like to receive only one copy per household, you should